EnBio Holdings, Inc

6092.T
Specialty Business Services
2026/11/13 19:59 Updated
Market Cap: $38.6M (¥6.2B)
Stock Price: $4.75 (¥759)
Exchange Rate: 1 USD = ¥159.74

Fiscal Year Ending March 2027 Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)

For the interim period of the fiscal year ending March 2027, consolidated revenue was in the 5.7 billion yen range, ordinary income was approximately 642 million yen, and interim net income attributable to owners of the parent was approximately 394 million yen. Revenue increased slightly year‑on‑year while net income declined. By segment, Environmental Solutions recorded lower revenue and profit, Real Estate Revitalization posted significant profit growth, and Renewable Energy saw revenue growth but deteriorating margins. Full‑year forecasts for 2027 are unchanged.

Importance:
Page Updated: November 14, 2026
IR Disclosure Date: November 13, 2026

Key Figures

  • Revenue: 5,756 million yen
  • Ordinary Income: 642 million yen
  • Net Income Attributable to Owners of Parent (Interim): 394 million yen

AI要約

Overview of Results

For the interim period from April 1, 2026 to September 30, 2026, consolidated revenue was 5,756 million yen (Year‑over‑Year 1.3% increase) and ordinary income was 642 million yen (Year‑over‑Year 7.3% increase). The overall results were driven by lower revenue and profit in the Environmental Solutions segment, significant profit growth in the Real Estate Revitalization segment, and revenue growth in the Renewable Energy segment. Interim net income attributable to owners of the parent decreased to 394 million yen (Year‑over‑Year -27.5%).

Outlook and Key Focus Areas

The consolidated earnings forecast for the fiscal year ending March 2027 remains unchanged from the time of disclosure. Segment priorities include improving profitability in Environmental Solutions, enhancing earnings quality in Real Estate Revitalization, and expanding PPA‑related business in Renewable Energy. A financial results presentation video will be made available on the company website.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

EnBio Holdings, Inc

Company overview · Stock price · Financial data · All IR

View company page →